January 18 2010 11:32 PM EST
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2026 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Scientists at the Gladstone Institute of Virology and Immunology have discovered an agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection. Surfen might be used to supplement current HIV microbicides to greatly reduce HIV transmission during sexual contact.
The discovery was made by Nadia Roan, Ph.D., a senior fellow in the laboratory of GIVI director Warner Greene, MD, Ph.D.
Surfen is a small molecule that inhibits the actions of certain polysaccharide molecules called heparan sulfate proteoglycans, which are found on the surface of cells. Importantly for HIV infection, it also interferes with the action of semen-derived enhancer of viral infection. The discovery was published in the current issue of the Journal of Biological Chemistry.
"Surprisingly, although HIV readily replicates once inside the body, the virus struggles to establish a beachhead of infection during sexual transmission," says Greene, who is senior author of the study. "We have been studying SEVI, a naturally occurring factor present in semen that can make HIV thousands of times more infectious. Knowing more about surfen, a SEVI inhibitor, might enable us to lower transmission rates of HIV."
SEVI is a breakdown product of prostatic acid phosphatase, a common protein in semen. Under certain conditions, SEVI can increase HIV infectivity 100,000 times by facilitating the attachment of viruses to target cells. Because the majority of all HIV infections are thought to result from sexual contact (during which semen is either the vehicle carrying HIV or is present during the infection process), SEVI might have a significant impact on HIV transmission rates. Surfen interferes with the binding of SEVI to both target cells and HIV-1 virions but does not cause the SEVI fibrils to break up.
"Because SEVI can so greatly enhance HIV infectivity, supplementing current HIV microbicide candidates with SEVI inhibitors, such as surfen, might increase their potency and overall effectiveness," Greene explains.
From our Sponsors
Most Popular
Plus: Featured Video
Latest Stories
How to find an HIV-competent healthcare provider, according to advocates
May 19 2026 4:55 PM
Can a single infusion of immune cells suppress HIV for years?
May 11 2026 11:39 AM
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
April 29 2026 3:32 PM
National HIV advocacy group's CEO rejects claims of crisis
April 21 2026 5:14 PM
Beyond awareness: How youth leadership is reshaping the HIV response
April 10 2026 9:12 AM
Saving public health? AIDS United's new CEO has a plan
March 23 2026 9:48 AM
Struggling with daily HIV meds? Monthly shots may be the answer
March 20 2026 7:12 AM
Did you know over half of HIV-positive people in the world are female?
March 09 2026 6:47 PM
Why are Black people still the most affected by HIV criminalization?
February 27 2026 8:44 PM
What to know about HIV testing and treatment if you’re Black and LGBTQ+
February 24 2026 9:04 AM
6 Black activists who changed the HIV/AIDS response in America
February 09 2026 9:55 AM
National Black HIV/AIDS Awareness Day: a time for action on many fronts
February 07 2026 3:49 PM
Black Americans are disproportionately criminalized for living with HIV. Here's how
February 06 2026 4:26 PM
13 Black community organizations fighting HIV in the U.S. you should know
February 03 2026 10:45 AM
Meet the activist who wants people living with HIV to know they’re still sexy
January 28 2026 10:02 AM
An HIV breakthrough is here. Let's not let it go to waste
January 21 2026 12:40 PM
HIV-positive men stage 'Kiss-In' protest at U.S.-Mexico border
December 01 2025 12:56 PM





























































